« Back to Record
Citation APA

Chan, D. L. H. D., Hayes, A. A., Karfis, I., Conner, A., Mileva, M., Bernard, E., Schembri, G., Navalkissoor, S., Gnanasegaran, G., Pavlakis, N., Marin, C., Vanderlinden, B., Flamen, P., Roach, P., Caplin, M. E., Toumpanakis, C., & Bailey, D. D. (2024). [18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study. The Journal of nuclear medicine, 65(2), 185-191. doi:10.2967/jnumed.123.266346


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371984

Chan, D. L. H. D., Hayes, A. A., Karfis, I., Conner, A., Mileva, M., Bernard, E., Schembri, G., Navalkissoor, S., Gnanasegaran, G., Pavlakis, N., Marin, C., Vanderlinden, B., Flamen, P., Roach, P., Caplin, M. E., Toumpanakis, C., & Bailey, D. D. (2024). [18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study. The Journal of nuclear medicine, 65(2), 185-191. doi:10.2967/jnumed.123.266346